Page 56 - OR-1-1

Furthermore, organoid technology plays a crucial role well as the correction of gene mutations in organoids using
114
in drug metabolism and toxicology studies. Given their CRISPR and other gene-editing technologies, which offers
ability to mimic the physiological functions of human new possibilities for curing previously incurable diseases.
tissues, organoids can be used to evaluate drug metabolism In summary, organoid technology is a game-changer
processes and potential toxicities in vivo. For instance, liver for personalized medicine and precision treatment.
organoids can be employed to study drug-metabolizing By simulating the unique disease environment of each
enzyme activities and toxicological responses, thereby patient, organoids enable the development of treatment
providing more accurate data for drug safety assessments. 115 plans tailored to an individual’s genetic, molecular, and
In summary, the application prospects of organoid physiological characteristics. This not only enhances the
technology in drug discovery and screening are vast. By effectiveness of treatments but also minimizes the time
offering more accurate and scalable models, organoids and resources spent on ineffective therapies. Moreover,
not only accelerate drug development but also provide organoids facilitate the advancement of precision medicine
robust support for personalized medicine and precision by allowing for the testing of various therapeutic approaches
therapy. With continuous technological advancements, on patient-specific organoids before clinical application.
the application of organoids in drug research will become This leads to more precise and effective treatment options,
increasingly widespread, contributing significantly to offering patients a greater chance of successful outcomes.
human health and well-being.
5.3. Regenerative medicine and tissue engineering
5.2. Personalized medicine and precision therapies Another critical area of organoid therapeutics lies in

Organoids are revolutionizing personalized medicine by regenerative medicine. Organoids, with their ability to self-
enabling the development of precision therapies tailored organize into 3D structures that closely resemble native
to the genetic, molecular, and physiological characteristics tissues, hold tremendous promise for developing tissue-
of individual patients. By generating organoids from a engineered solutions for organ replacement or repair. For
118
patient’s own cells, it becomes possible to replicate the example, organoids derived from stem cells can be used to
patient’s unique disease environment, offering a platform regenerate damaged tissues in diseases such as liver failure,
for testing the effectiveness of various therapeutic strategies heart disease, and neurodegenerative conditions. 107,119,120
before clinical application. 116 More recently, bone organoids have gained attention

For example, in oncology, PDOs can be used to predict for their potential to directly address bone defects and
how tumors respond to different chemotherapies or injuries. These bone organoids, which recapitulate
121
targeted therapies. This approach significantly improves the structural and functional properties of native bone
the likelihood of selecting the most effective treatment, tissue, can be implanted to promote bone regeneration,
reducing the trial-and-error process that often characterizes offering a direct therapeutic approach for bone fractures,
109
cancer therapy. Specifically, researchers can utilize tumor osteoarthritis, or other skeletal disorders. 122,123 Besides
tissues from patients to generate PDOs, which are then a recent study reported significant advancements in
subjected to testing with a variety of drugs to determine cardiac tissue engineering. The study demonstrated the
which compounds are most effective in inhibiting tumor development of a 3D-bioprinted chambered organoid
growth or inducing cell death. This personalized approach capable of replicating the structure and function of the
not only enhances therapeutic efficacy but also reduces human heart. Using a bioink containing human induced
124
the time and resources patients expend on ineffective pluripotent stem cells, the researchers successfully created
treatments. functional cardiac tissue with electromechanical activity.
Moreover, organoids can be utilized to study genetic This innovation highlights the potential of 3D bioprinting
variations, providing insights into the underlying in generating complex cardiac models for applications in
mechanisms of genetic diseases. When studying genetic drug testing and disease modeling.
diseases such as cystic fibrosis, researchers can generate In recent advancements in neurotechnology, the
organoids from patient cells and use gene-editing development of organoid-brain-computer interfaces
technologies (such as CRISPR) to correct disease-related (OBCIs) has emerged as a promising approach for repairing
gene mutations. By comparing the phenotypes and brain damage. Hu et al. presented a study on the use
117
125
functions of organoids before and after editing, researchers of OBCIs for neurofunctional repair after brain injury.
can gain a better understanding of how these mutations They demonstrated that these interfaces, which combine
lead to disease and assess the effectiveness of potential brain organoids with BCIs, can enhance the survival,
gene therapies. The knowledge gained from these studies differentiation, and integration of transplanted organoids
can facilitate the development of gene-based therapies, as in the host brain. The study revealed that electrical

Volume 1 Issue 1 (2025) 9 doi: 10.36922/OR025040007